PT - JOURNAL ARTICLE AU - Binyamin-Netser, Reut AU - Handelzalts, Shirley AU - Goldhamer, Noy AU - Avni, Inbar AU - Tayer, Adi Yeshurun AU - Koren, Yogev AU - Levy, Ofri Bibas AU - Kramer, Shilo AU - Haim, Simona Bar AU - Shmuelof, Lior TI - Neurotechnology-based intensive upper-extremity supplementary training for inpatients with sub-acute stroke: A feasibility study AID - 10.1101/2023.11.18.23298626 DP - 2023 Jan 01 TA - medRxiv PG - 2023.11.18.23298626 4099 - http://medrxiv.org/content/early/2023/11/18/2023.11.18.23298626.short 4100 - http://medrxiv.org/content/early/2023/11/18/2023.11.18.23298626.full AB - Background Intensive and high-dose upper extremity training, concentrating on movement quality in the early phase after a stroke, can enhance motor recovery compared to standard care. Unfortunately, such programs do not exist due to limited resources, patient compliance, and administrative challenges.Objective To examine the feasibility and potential efficacy, and to evaluate the resources of an intensive technology-based upper extremity training emphasizing movement quality during inpatient stroke rehabilitation.Methods Twelve subjects with hemiparesis underwent 40 60-minute sessions over a 4-week period, in addition to standard care. The training included two game-based virtual reality platforms to practice proximal (tech 1) and distal (tech 2) movements with daily assessments.Results Eight subjects completed the entire protocol, three subjects completed 34–38 sessions, and one subject completed only 27 sessions. The mean time on each task was 35±4 (tech 1) and 37±2 (tech 2) minutes per hour. The intervention was perceived as motivating and enjoyable [Intrinsic Motivation Inventory (IMI) enjoyment and interest= 6.49±0.66 out of 7] and was not associated with pain [Visual Analogue Scale (VAS) mean= 2.00±2.32]. Subjects showed large improvements in all impairment measurements (mean FMA delta= 16.5 points and ARAT delta= 22.9 points).Conclusions The results support the feasibility of a high-dose high-intensity supplementary training protocol during sub-acute hospitalization and provide suggestive evidence of its efficacy.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04737395Funding StatementThis work was supported by the Israeli Science Foundation grant 1244/22 to LS.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Regional Ethical Review Board at Sheba Medical Center, Israel (Approval Number 6218-19-SMC), and registered with ClinicalTrials.gov (NCT04737395) prior to the start of enrollment. All subjects signed a consent form before performing the experiment.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors